Biogen
BIIB
BIIB
999 hedge funds and large institutions have $36B invested in Biogen in 2023 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 319 increasing their positions, 359 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
999
Holders Change
+7
Holders Change %
+0.71%
% of All Funds
15.75%
Holding in Top 10
18
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.26%
% of All Funds
0.28%
New
97
Increased
319
Reduced
359
Closed
84
Calls
$555M
Puts
$599M
Net Calls
-$44.6M
Net Calls Change
-$115M
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$968M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$253M |
| 3 |
Amundi
Paris,
France
|
+$174M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$105M |
| 5 |
JPMorgan Chase & Co
New York
|
+$103M |
Top Sellers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$639M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$273M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$150M |
| 4 |
D.E. Shaw & Co
New York
|
-$139M |
| 5 |
Millennium Management
New York
|
-$134M |